Immediate Impact
3 by Nobel laureates 54 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Neoadjuvant Chemoimmunotherapy for NSCLC
2024 Standout
Works of Xiaobo Ma being referenced
Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial
2022
Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Xiaobo Ma | 85 | 93 | 66 | 108 | 94 | 49 | 396 | |
| Jingjing Guo | 66 | 90 | 48 | 147 | 70 | 46 | 414 | |
| Aptullah Haholu | 112 | 70 | 44 | 146 | 51 | 37 | 445 | |
| Wenqing Hu | 79 | 129 | 32 | 143 | 85 | 61 | 424 | |
| Xiaona Chang | 35 | 103 | 48 | 137 | 49 | 46 | 401 | |
| Qiang Wei | 132 | 117 | 50 | 72 | 108 | 56 | 418 | |
| Ming Xia | 50 | 53 | 49 | 90 | 104 | 44 | 425 | |
| Takashi Sekikawa | 71 | 157 | 31 | 112 | 141 | 33 | 396 | |
| Takayuki Imai | 176 | 101 | 19 | 86 | 68 | 51 | 388 | |
| Shengnan Zhao | 58 | 108 | 37 | 131 | 168 | 53 | 454 | |
| Çiğdem Vural | 138 | 61 | 33 | 83 | 81 | 56 | 379 |
All Works
Login with ORCID to disown or claim papers
Loading papers...